the global internal neurostimulation market in 2014

1
Internal Neurostimulation
Internal Neurostimulation A Journey From
2015-2019.
www.micromarketmonitor.com
2
Internal Neurostimulation
The spinal cord stimulation segment accounted for
the largest share of 57.5 in the global internal
neurostimulation market in 2014.
www.micromarketmonitor.com
3
Internal Neurostimulation
About OSS/BSS

• This segment was valued at 2,788.0 million in
  2014, and is expected to reach 4,819.9 million
  by 2019, at a CAGR of 11.6 during the forecast
  period.
• http//www.micromarketmonitor.com/contact/15409191
  09-speak_to_analyst.html

www.micromarketmonitor.com
4
Internal Neurostimulation

• The deep brain stimulation modality segment is
  the second-largest segment that was valued at
  861.2 million in 2014, and is expected to reach
  1,581.4 million by 2019, at a CAGR of 12.9 from
  2014 to 2019. The vagus nerve stimulation (VNS)
  segment is expected to grow at a CAGR of 13.0
  during the forecast period.

www.micromarketmonitor.com
5
Cloud Infrastructure
Internal Neurostimulation

• Boston Scientific Corporation (U.S.)
• Cyberonics, Inc. (U.S.)
• Dynatronics Corporation (U.S.)
• EnteroMedics Inc. (U.S.)
• Medtronic Inc. (U.S.)
• St. Jude Medical, Inc
• St. Jude Medical, Inc. (U.S.)

www.micromarketmonitor.com
6
Internal Neurostimulation
Segmented by Global- overall growth of the
global neurostimulation market include research
activities in the field of internal
neurostimulation, growing awareness associated
with the benefits of these techniques, government
funding, and growing prevalence of neurological
disorders. http//www.micromarketmonitor.com/cont
act/1540919109-request_for_customization.html
www.micromarketmonitor.com
7
Internal Neurostimulation
Contact 1-888-502-0539 Mail Us your Specific
Requirement at sales_at_micromarketmonitor.com Pleas
e find more information _at_ http//www.micromarketmo
nitor.com/market-report/global-internal-neurostimu
lation-reports-1540919109.html
www.micromarketmonitor.com